A top five pharmaceutical company is seeking novel approaches and emerging science targeting neuro-immune crosstalk, to promote deep healing and sustained response in autoimmune and inflammatory diseases. Approaches should complement or surpass existing anti-inflammatory treatments. Solutions that target multiple nodes or pathways in a disease to return tissue(s) to homeostasis are of high interest.
Approaches of Interest:
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
Technology
Academic Researcher
Centre of Excellence
Research Project
Spinout Company
Biotech Asset
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.